Traws Pharma (TRAW) Tops Q2 EPS by 27c
Traws Pharma (NASDAQ: TRAW) reported Q2 EPS of ($0.16), $0.27 better than the analyst estimate of ($0.43).
For earnings history and earnings-related data on Traws Pharma (TRAW) click here.
Traws Pharma (NASDAQ: TRAW) reported Q2 EPS of ($0.16), $0.27 better than the analyst estimate of ($0.43).
For earnings history and earnings-related data on Traws Pharma (TRAW) click here.